Table 2.

Postoperative features

Outcome	Number of patients with feature/total number of patients with available data (%)
Post-operative use of DA	11/23 (48)
Subjects with persistent post-operative PRL hypersecretion	13/26 (50)
Any post-operative hypopituitarism	6/29 (21)
ACTH deficiency	2/17 (12)
TSH deficiency	4/17 (24)
GH deficiency	1/16 (6)
FSH/LH deficiency	3/11 (27)
Tumor histology
Atypical adenomas	3/26 (12)
Positive p53	6/12 (50)
Increased mitoses	6/11 (55)
Radiologic follow up
Post-operative residual adenoma	11/20 (55)
Growth of post-operative residual on MRI	4/9 (44)
De novo MRI recurrences	3/8 (38)